A Phase 3, Randomized, Double-Blind, Active-Controlled Study to Evaluate the Effects of Bexagliflozin Versus Sitagliptin in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control by Metformin
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 06 Aug 2018
At a glance
- Drugs Bexagliflozin (Primary) ; Metformin; Sitagliptin
- Indications Type 2 diabetes mellitus
- Focus Registrational; Therapeutic Use
- Sponsors Theracos
- 06 Aug 2018 This trial has been completed in Hungary according to European Clinical Trials Database record.(End Date;2018-07-18)
- 20 Jul 2018 This trial has been completed in Spain according to European Clinical Trials Database record.
- 22 Jan 2018 Status changed from recruiting to active, no longer recruiting.